Jingjing Wen

401 total citations
47 papers, 239 citations indexed

About

Jingjing Wen is a scholar working on Molecular Biology, Hematology and Surgery. According to data from OpenAlex, Jingjing Wen has authored 47 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Hematology and 8 papers in Surgery. Recurrent topics in Jingjing Wen's work include Acute Myeloid Leukemia Research (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (6 papers). Jingjing Wen is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (6 papers). Jingjing Wen collaborates with scholars based in China, France and Australia. Jingjing Wen's co-authors include Mark Gibson, Jianda Hu, Lilin Liu, Lingfeng Liu, Fang Xu, Di Fu, Lingyan Wang, Li Wang, Weili Zhao and Ting Yang and has published in prestigious journals such as Blood, Chemical Engineering Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Jingjing Wen

37 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingjing Wen China 9 104 64 43 33 32 47 239
Monique E. Quaedackers Netherlands 9 78 0.8× 83 1.3× 35 0.8× 17 0.5× 54 1.7× 9 345
Vennila Gopal United States 7 136 1.3× 74 1.2× 46 1.1× 40 1.2× 132 4.1× 16 446
Domenico Somma United Kingdom 10 123 1.2× 35 0.5× 43 1.0× 12 0.4× 10 0.3× 11 223
Yueyue Fu China 9 167 1.6× 33 0.5× 52 1.2× 71 2.2× 7 0.2× 22 340
Tiago Bordeira Gaspar Portugal 8 75 0.7× 34 0.5× 22 0.5× 6 0.2× 41 1.3× 12 269
Florent Chuffart France 12 202 1.9× 33 0.5× 47 1.1× 18 0.5× 66 2.1× 30 364
Eman Badr Egypt 9 78 0.8× 37 0.6× 48 1.1× 15 0.5× 14 0.4× 64 303
Manfei Si China 7 157 1.5× 49 0.8× 83 1.9× 30 0.9× 64 2.0× 13 392
Xiaoyan Ming China 9 181 1.7× 54 0.8× 76 1.8× 12 0.4× 67 2.1× 17 344
Audun Hanssen‐Bauer Norway 8 251 2.4× 119 1.9× 68 1.6× 16 0.5× 10 0.3× 8 359

Countries citing papers authored by Jingjing Wen

Since Specialization
Citations

This map shows the geographic impact of Jingjing Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Wen more than expected).

Fields of papers citing papers by Jingjing Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjing Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Wen. The network helps show where Jingjing Wen may publish in the future.

Co-authorship network of co-authors of Jingjing Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Wen. A scholar is included among the top collaborators of Jingjing Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Wen. Jingjing Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jiazheng, Zhengjun Wu, Jingjing Wen, et al.. (2025). UHRF1-mediated epigenetic reprogramming regulates glycolysis to promote progression of B-cell acute lymphoblastic leukemia. Cell Death and Disease. 16(1). 351–351. 2 indexed citations
2.
Li, Lingyan, Jingjing Wen, Xiaoyang Cheng, et al.. (2025). Facile Synthesis of N‐Doped Porous Carbon Materials Derived from Bombyx Mori Silk for High‐Performance Symmetric Supercapacitors. Chemistry - A European Journal. 31(22). e202404569–e202404569. 3 indexed citations
3.
Liu, Xiang, Song Liu, Jingcao Huang, et al.. (2025). The mitochondrial protease ClpP is a promising target for multiple myeloma treatment. Biochemical Pharmacology. 236. 116855–116855. 1 indexed citations
4.
Wen, Jingjing, et al.. (2024). Limb Salvage Using Lateral Circumflex Femoral Artery Graft for a Hand Vibration Syndrome. Plastic & Reconstructive Surgery Global Open. 12(7). e5978–e5978.
5.
Wen, Jingjing, et al.. (2024). Self-assembled herbal hydrogel for rectal administration therapy in ulcerative colitis. Chemical Engineering Journal. 503. 158477–158477. 12 indexed citations
6.
7.
Xu, Fang, et al.. (2024). Diagnosis of light‑chain deposition disease after renal transplantation: A case report and literature review. Experimental and Therapeutic Medicine. 28(3). 339–339.
8.
9.
Wen, Jingjing, Jiajie Yang, Lilin Liu, et al.. (2023). Valproic acid increases CAR T cell cytotoxicity against acute myeloid leukemia. Journal for ImmunoTherapy of Cancer. 11(7). e006857–e006857. 25 indexed citations
10.
Luo, Hongmei, Feng Yu, Fangfang Wang, et al.. (2023). Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma. Cancer Letters. 565. 216218–216218. 7 indexed citations
11.
Wang, Jing, et al.. (2023). Clinical study of falls among inpatients with hematological diseases and exploration of risk prediction models. Frontiers in Public Health. 11. 1150333–1150333. 2 indexed citations
12.
13.
14.
Wu, Zhengjun, Lingyan Wang, Jingjing Wen, et al.. (2023). Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia. Cellular Oncology. 46(6). 1709–1724. 2 indexed citations
15.
Feng, Yu, Jingcao Huang, Fangfang Wang, et al.. (2023). Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma. Life Sciences. 333. 122157–122157. 3 indexed citations
16.
Yan, Zi‐Xun, Jingjing Wen, Di Fu, et al.. (2021). CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis. Molecular Cancer. 20(1). 153–153. 24 indexed citations
17.
Li, Jiazheng, Yan Huang, Yun Zhang, et al.. (2021). Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma. Medical Oncology. 38(4). 33–33. 10 indexed citations
18.
Wang, Yong, et al.. (2021). Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 47(1). 83–83. 1 indexed citations
19.
Hu, Jianda, et al.. (2019). Targeting Nucleolin for Reversal of Chemotherapy Resistance in Acute Lymphoblastic Leukemia. Blood. 134(Supplement_1). 5058–5058. 2 indexed citations
20.
Wen, Jingjing, Jiali Zhou, Zhibin Liu, & Caigang Xu. (2014). [Clinical outcome of 489 patients with diffuse large B-cell lymphoma and associated factors].. PubMed. 45(3). 519–23.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monique E. Quaedackers Breakdown of academic impact, for papers by Vennila Gopal Breakdown of academic impact, for papers by Domenico Somma Breakdown of academic impact, for papers by Yueyue Fu Breakdown of academic impact, for papers by Tiago Bordeira Gaspar Breakdown of academic impact, for papers by Florent Chuffart Breakdown of academic impact, for papers by Eman Badr Breakdown of academic impact, for papers by Manfei Si Breakdown of academic impact, for papers by Xiaoyan Ming Breakdown of academic impact, for papers by Audun Hanssen‐Bauer
Rankless by CCL
2026